A detailed history of Ubs Asset Management Americas Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 44,668 shares of FLGT stock, worth $819,211. This represents 0.0% of its overall portfolio holdings.

Number of Shares
44,668
Previous 38,770 15.21%
Holding current value
$819,211
Previous $760,000 27.63%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$19.6 - $25.06 $115,600 - $147,803
5,898 Added 15.21%
44,668 $970,000
Q2 2024

Aug 13, 2024

BUY
$19.09 - $22.57 $292,096 - $345,343
15,301 Added 65.2%
38,770 $760,000
Q1 2024

May 15, 2024

BUY
$21.55 - $29.29 $70,791 - $96,217
3,285 Added 16.28%
23,469 $509,000
Q3 2023

Nov 13, 2023

BUY
$26.74 - $40.81 $52,009 - $79,375
1,945 Added 10.66%
20,184 $539,000
Q1 2023

May 15, 2023

SELL
$29.39 - $36.27 $148,625 - $183,417
-5,057 Reduced 21.71%
18,239 $569,000
Q4 2022

Feb 14, 2023

BUY
$29.23 - $40.28 $75,179 - $103,600
2,572 Added 12.41%
23,296 $693,000
Q3 2022

Nov 14, 2022

SELL
$37.92 - $63.74 $28,250 - $47,486
-745 Reduced 3.47%
20,724 $789,000
Q2 2022

Aug 12, 2022

SELL
$47.98 - $62.75 $211,879 - $277,104
-4,416 Reduced 17.06%
21,469 $1.17 Million
Q1 2022

May 16, 2022

BUY
$49.85 - $96.11 $11,515 - $22,201
231 Added 0.9%
25,885 $1.62 Million
Q4 2021

Feb 14, 2022

BUY
$77.3 - $105.0 $438,213 - $595,245
5,669 Added 28.37%
25,654 $2.58 Million
Q3 2021

Nov 15, 2021

SELL
$74.87 - $110.87 $309,512 - $458,336
-4,134 Reduced 17.14%
19,985 $1.8 Million
Q2 2021

Aug 16, 2021

BUY
$66.8 - $100.45 $204,140 - $306,975
3,056 Added 14.51%
24,119 $2.22 Million
Q1 2021

May 14, 2021

SELL
$59.3 - $183.85 $8,124 - $25,187
-137 Reduced 0.65%
21,063 $2.04 Million
Q4 2020

Mar 01, 2021

BUY
$31.01 - $52.1 $657,412 - $1.1 Million
21,200 New
21,200 $1.1 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $555M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.